Head & Neck Cancers | Specialty

The OncLive Head and Neck Cancer condition center page is a comprehensive resource for clinical news and expert insights on treatment for patients with head and neck cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research within head and neck cancer.

The Use of Immunotherapy in HNSCC

March 21st 2016

Supportive Care and Long-Term Quality of Life in HNSCC

March 21st 2016

When to Use Cetuximab or Chemotherapy in HNSCC

March 21st 2016

Examining the Use of Cetuximab for HNSCC

March 21st 2016

Chemotherapy Procedures for Advanced HNSCC

March 21st 2016

Roles for Radiotherapy in Head and Neck Cancer

March 21st 2016

Radiation Therapy Approaches to Head and Neck Cancer

March 21st 2016

Surgical Management of HNSCC

March 21st 2016

Head and Neck Cancer: Treatment of Advanced Disease

March 21st 2016

Treatment Approaches in Head and Neck Cancer

March 21st 2016

Multidisciplinary Care in Head and Neck Cancer

March 21st 2016

Diagnosis, Staging, and Prognosis of Head and Neck Cancer

March 21st 2016

Challenges in Implementing Widespread HPV Vaccination

March 21st 2016

HPV Infection in Pathogenesis of Head and Neck Cancers

March 21st 2016

Biology of Head and Neck Squamous Cell Carcinoma

March 21st 2016

Dr. Schoenfeld on Immunologic Effects of Chemotherapy and Radiation in Head and Neck Cancer

March 9th 2016

Jonathan D. Schoenfeld, MD, MPH, physician, assistant professor of Radiation Oncology, Harvard Medical School, Dana Farber Cancer Center on the immunologic effects of chemotherapy and radiation in head and neck cancer.

Dr. Cohen on Lenvatinib in First- or Second-Line Thyroid Cancer

March 9th 2016

Ezra Cohen, MD, Associate Director, Professor of Medicine Moores Cancer Center, UC San Diego, discusses if lenvatinib should be used in the frontline or second-line setting in differentiated thyroid cancer.

Dr. Adelstein on Adjuvant Therapy for Oral Cancer

March 8th 2016

David Adelstein, MD, Department of Hematology and Oncology, Cleveland Clinic, discusses adjuvant therapy options for patients with oral cancer.

Prognostic Significance of Post-Treatment PET/CT Following Salvage Re-irradiation of Head and Neck Cancers

March 7th 2016

Researchers explored the prognostic significance of PET/CT following re-irradiation in patients with head and neck cancer.

Dr. Frakes on Managing Late Toxicities Associated With Treatment for HPV+ Oropharyngeal SCC

February 26th 2016

Jessica Frakes, MD, assistant professor of Radiation Oncology, Department of Radiation Oncology, Moffitt Cancer Center, discusses management of toxicities associated with treatment of patients with HPV-positive oropharyngeal squamous cell carcinoma.